Postpartum tuberculosis incidence and mortality among HIV-infected women and their infants in Pune, India, 2002-2005

Clinical Infectious Diseases

Volumn 45, Issue 2, 2007, Pages 241-249

  Gupta, Amita ^a,c   Nayak, Uma ^b   Ram, Malathi ^b   Bhosale, Ramesh ^a   Patil, Sandesh ^a   Basavraj, Anita ^a   Kakrani, Arjun ^a   Philip, Sheeja ^a   Desai, Dipali ^a   Sastry, Jayagowri ^a   Bollinger, Robert C ^a,b  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^c Global Health Education   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; ISONIAZID; RIFAMPICIN; NEVIRAPINE; TUBERCULOSTATIC AGENT;

ADULT; ARTICLE; CD4 LYMPHOCYTE COUNT; CHILD DEATH; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INCIDENCE; INDIA; INFECTION PREVENTION; MAJOR CLINICAL STUDY; MATERNAL MORBIDITY; MATERNAL MORTALITY; MORTALITY; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROSPECTIVE STUDY; PUERPERIUM; SCREENING; TUBERCULIN TEST; TUBERCULOSIS; AGE DISTRIBUTION; AIDS RELATED COMPLEX; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DISEASE TRANSMISSION; INFANT; NEWBORN; PHASE 3 CLINICAL TRIAL; PREGNANCY; PREGNANCY COMPLICATION; RANDOMIZED CONTROLLED TRIAL; RISK ASSESSMENT; SEX RATIO; STATISTICS; SURVIVAL; THIRD TRIMESTER PREGNANCY; URBAN POPULATION;

AGE DISTRIBUTION; AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANTITUBERCULAR AGENTS; DISEASE TRANSMISSION, VERTICAL; FEMALE; HUMANS; INCIDENCE; INDIA; INFANT; INFANT, NEWBORN; NEVIRAPINE; POSTPARTUM PERIOD; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PREGNANCY TRIMESTER, THIRD; PROSPECTIVE STUDIES; RISK ASSESSMENT; SEX DISTRIBUTION; SURVIVAL ANALYSIS; TUBERCULOSIS; URBAN POPULATION;

EID: 34447094327     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/518974     Document Type: Article

References (40)

1. World Health Organization. HIV/TB clinical manual. 2nd ed. Geneva, Switzerland: World Health Organization, 2004.
2. Kali PB, Gray GE, Violari A, Chaisson RE, McIntyre JA, Martinson NA. Combining PMTCT with active case finding for tuberculosis. J Acquir Immune Defic Syndr 2006; 42:379-81.
3. Nachega J, Coetzee J, Adendorff T, et al. Tuberculosis active casefinding in a mother-to-child HIV transmission prevention programme in Soweto, South Africa. AIDS 2003; 17:1398-400.
4. Mofenson LM, Rodriguez EM, Hershow R, et al. Mycobacterium tuberculosis infection in pregnant and nonpregnant women infected with HIV in the Women and Infants Transmission Study. Arch Intern Med 1995; 155:1066-72.
5. Pillay T, Khan M, Moodley J, Adhikari M, Coovadia H. Perinatal tuberculosis and HIV-1: considerations for resource-limited settings. Lancet Infect Dis 2004; 4:155-65.
6. Juneja Y, Goel U, Sood M. Changing trends in maternal mortality over a decade. Int J Gynaecol Obstet 1994; 46:265-9.
7. Ahmed Y, Mwaba P, Chintu C, Grange JM, Ustianowski A, Zumla A. A study of maternal mortality at the University Teaching Hospital, Lusaka, Zambia: the emergence of tuberculosis as a major non-obstetric cause of maternal death. Int J Tuberc Lung Dis 1999; 3:675-80.
8. Khan M, Pillay T, Moodley J, Connolly C. Maternal mortality associated with tuberculosis-HIV coinfection in Durban, South Africa. Ann N Y Acad Sci 2000; 918:367-9.
9. Pillay T, Khan M, Moodley J, et al. The increasing burden of tuberculosis in pregnant women, newborns and infants under 6 months of age in Durban, KwaZulu-Natal. S Afr Med J 2001; 91:983-7.
10. Marais BJ, Gie RP, Schaaf HS, et al. The natural history of childhood intra-thoracic tuberculosis: a critical review of literature from the prechemotherapy era. Int J Tuberc Lung Dis 2004; 8:392-402.
11. Marais BJ, Gie RP, Schaaf HS, et al. The clinical epidemiology of childhood pulmonary tuberculosis: a critical review of literature from the pre-chemotherapy era. Int J Tuberc Lung Dis 2004; 8:278-85.
12. TB Control of India. TB India 2006 RNTCP status report - DOTS for all: all for DOTS. Available at: http://www.tbcindia.org/documents.asp#. Accessed 28 June 2006.
13. World Health Organization (WHO). Global tuberculosis control - surveillance, planning, financing: WHO report 2006. Geneva, Switzerland: WHO, 2006.
14. United Nations AIDS Program. 2006 Report on the global AIDS epidemic. 2006. Available at: http://www.unaids.org/en/HIV_data/2006GlobalReport/default. asp. Accessed 12 July 2006.
15. Padmapriyadarsini C, Swaminathan S. Preventive therapy for tuberculosis in HIV-infected individuals. Indian J Med Res 2005; 121:415-23.
16. Huebner RE, Schein MF, Bass JB Jr. The tuberculin skin test. Clin Infect Dis 1993; 17:968-75.
17. Targeted tuberculin testing and treatment of latent tuberculosis infection. American Thoracic Society. MMWR Recomm Rep 2000; 49(RR-6):1-51.
18. Enarson PM, Enarson DA, Gie R. Management of tuberculosis in children in low-income countries. Int J Tuberc Lung Dis 2005; 9:1299-304.
19. Burnham K, Anderson D. Model selection and multimodel inference: a practical information-theoretic approach. New York: Springer-Verlag, 2002.
20. Selwyn PA, Hartel D, Lewis VA, et al. A prospective study of the risk of tuberculosis among intravenous drug users with human immunodeficiency virus infection. N Engl J Med 1989; 320:545-50.
21. Whalen CC, Nsubuga P, Okwera A, et al. Impact of pulmonary tuberculosis on survival of HIV-infected adults: a prospective epidemiologic study in Uganda. AIDS 2000; 14:1219-28.
22. Swaminathan S, Ramachandran R, Baskaran G, et al. Risk of development of tuberculosis in HIV-infected patients. Int J Tuberc Lung Dis 2000; 4:839-44.
23. Antonucci G, Girardi E, Raviglione MC, Ippolito G. Risk factors for tuberculosis in HIV-infected persons: a prospective cohort study. The Gruppo Italiano di Studio Tubercolosi e AIDS (GISTA). JAMA 1995; 274:143-8.
24. Lawn SD, Badri M, Wood R. Tuberculosis among HIV-infected patients receiving HAART: long term incidence and risk factors in a South African cohort. AIDS 2005; 19:2109-16.
25. Golub JE, Saraceni V, Cavalcante S, et al. The impact of antiretroviral therapy and isoniazid preventative therapy on tuberculosis incidence in HIV-infected patients in Rio de Janeiro, Brazil. AIDS (in press).
26. Day JH, Grant AD, Fielding KL, et al. Does tuberculosis increase HIV load? J Infect Dis 2004; 190:1677-84.
27. + T-cell count and high HIV viral load precede the development of tuberculosis disease in a cohort of HIV-positive ethiopians. Int J Tuberc Lung Dis 2003; 7:110-6.
28. Yancey MK. Host defenses and bacterial resistance. Obstet Gynecol Clin North Am 1992; 19:413-34.
29. Saraiya UB, Bhalerao SA. Pregnancy and tuberculosis. In: Krishna U, ed. Pregnancy at risk: current concepts. 4th ed. New Delhi, India: The Federation of Obstetric and Gynecological Societies of India, Jaypee Brothers Medical Publishers, 2001: 132-7.
30. Robinson CA, Rose NC. Tuberculosis: current implications and management in obstetrics. Obstet Gynecol Surv 1996; 51:115-24.
31. Newell ML, Coovadia H, Cortina-Borja M, Rollins N, Gaillard P, Dabis F. Mortality of infected and uninfected infants born to HIV-infected mothers in Africa: a pooled analysis. Lancet 2004; 364:1236-43.
32. Zar HJ, Cotton MF, Strauss S, et al. Effect of isoniazid prophylaxis on mortality and incidence of tuberculosis in children with HIV: randomised controlled trial. BMJ 2007; 334:136.
33. Radhakrishna S, Frieden TR, Subramani R. Association of initial tuberculin sensitivity, age and sex with the incidence of tuberculosis in south India: a 15-year follow-up. Int J Tuberc Lung Dis 2003; 7:1083-91.
34. Pai M, Gokhale K, Joshi R, et al. Mycobacterium tuberculosis infection in health care workers in rural India: comparison of a whole-blood interferon gamma assay with tuberculin skin testing. JAMA 2005; 293:2746-55.
35. Franks AL, Binkin NJ, Snider DE Jr, Rokaw WM, Becker S. Isoniazid hepatitis among pregnant and postpartum Hispanic patients. Public Health Rep 1989; 104:151-5.
36. Boggess KA, Myers ER, Hamilton CD. Antepartum or postpartum isoniazid treatment of latent tuberculosis infection. Obstet Gynecol 2000; 96:757-62.
37. Woldehanna S, Volmink J. Treatment of latent tuberculosis infection in HIV infected persons. Cochrane Database Syst Rev 2004:CD000171.
38. Lawn SD, Myer L, Bekker LG, Wood R. Burden of tuberculosis in an antiretroviral treatment programme in sub-Saharan Africa: impact on treatment outcomes and implications for tuberculosis control. AIDS 2006; 20:1605-12.
39. World Health Organization Global Tuberculosis Programme. Policy statement on preventive therapy against tuberculosis in people living with HIV. Geneva, Switzerland: World Health Organization, 1998.
40. Grant AD, Charalambous S, Fielding KL, et al. Effect of routine isoniazid preventive therapy on tuberculosis incidence among HIV-infected men in South Africa: a novel randomized incremental recruitment study. JAMA 2005; 293:2719-25.